SEC Form 4 · accession 0001450324-16-000016
AIM ImmunoTech Inc. · AIM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Thomas K. Equels
Officer — CEO, President · Director
Period of report
Dec 22, 2016
Accepted (ET)
Dec 23, 2016 · 12:31 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000946644
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Dec 22, 2016 | P | 68,493 | $0.73 | A | 220,455 | D |
Table II — derivative securities
No Table II lines on this filing.